Atea Pharmaceuticals Inc. (AVIR): Price and Financial Metrics

Atea Pharmaceuticals Inc. (AVIR): $3.13

0.01 (+0.32%)

POWR Rating

Component Grades

Momentum

F

Stability

C

Sentiment

Quality

C

Add AVIR to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#124 of 336

in industry

AVIR Price/Volume Stats

Current price $3.13 52-week high $4.60
Prev. close $3.12 52-week low $2.75
Day low $3.09 Volume 36,698
Day high $3.16 Avg. volume 424,968
50-day MA $3.20 Dividend yield N/A
200-day MA $3.50 Market Cap 264.37M

AVIR Stock Price Chart Interactive Chart >


Atea Pharmaceuticals Inc. (AVIR) Company Bio


Atea Pharmaceuticals, Inc. is a clinical stage company, which focuses on discovering, developing, and commercializing antiviral therapeutics. Its product pipelines include Coronaviridae, Flaviviridae, and Paramyxovirdae. The company was founded by Jean-Pierre Sommadossi and David Chu in July 2012 and is headquartered in Boston, MA.


AVIR Latest News Stream


Event/Time News Detail
Loading, please wait...

AVIR Latest Social Stream


Loading social stream, please wait...

View Full AVIR Social Stream

AVIR Price Returns

1-mo -6.85%
3-mo -10.57%
6-mo -7.12%
1-year -24.58%
3-year -54.44%
5-year N/A
YTD -6.57%
2024 9.84%
2023 -36.59%
2022 -46.20%
2021 -78.60%
2020 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!